These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25035310)
1. Recognition and treatment of depressive symptoms in Parkinson's disease: the NPF dataset. Bega D; Wu SS; Pei Q; Schmidt PN; Simuni T J Parkinsons Dis; 2014; 4(4):639-43. PubMed ID: 25035310 [TBL] [Abstract][Full Text] [Related]
2. Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Althaus A; Becker OA; Spottke A; Dengler R; Schneider F; Kloss M; Eggert K; Oertel WH; Dillmann U; Herting B; Classen J; Dodel R Parkinsonism Relat Disord; 2008 Dec; 14(8):626-32. PubMed ID: 18406197 [TBL] [Abstract][Full Text] [Related]
3. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737 [TBL] [Abstract][Full Text] [Related]
4. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O; Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403 [TBL] [Abstract][Full Text] [Related]
5. [Benchmarking in patient care: depression in Parkinson's disease]. Spottke A; Schneider F; Dodel R Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798 [TBL] [Abstract][Full Text] [Related]
6. Caregiver strain in Parkinson's disease: national Parkinson Foundation Quality Initiative study. Oguh O; Kwasny M; Carter J; Stell B; Simuni T Parkinsonism Relat Disord; 2013 Nov; 19(11):975-9. PubMed ID: 23871587 [TBL] [Abstract][Full Text] [Related]
7. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability. Smith KM; Eyal E; Weintraub D; JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207 [TBL] [Abstract][Full Text] [Related]
8. What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study. Hassan A; Wu SS; Schmidt P; Malaty IA; Dai YF; Miyasaki JM; Okun MS Parkinsonism Relat Disord; 2012 Dec; 18 Suppl 3():S10-4. PubMed ID: 22776044 [TBL] [Abstract][Full Text] [Related]
17. The use of antidepressant medication in Parkinson's disease patients is not affected by the type of antiparkinson medication. Krøigård T; Christensen J; Wermuth L; Ritz B; Lassen CF J Parkinsons Dis; 2014; 4(3):327-30. PubMed ID: 24919822 [TBL] [Abstract][Full Text] [Related]
18. The role of mild depression in sleep disturbance and quality of life in Parkinson's disease. Naismith SL; Hickie IB; Lewis SJ J Neuropsychiatry Clin Neurosci; 2010; 22(4):384-9. PubMed ID: 21037122 [TBL] [Abstract][Full Text] [Related]
19. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Müller B; Assmus J; Herlofson K; Larsen JP; Tysnes OB Parkinsonism Relat Disord; 2013 Nov; 19(11):1027-32. PubMed ID: 23916654 [TBL] [Abstract][Full Text] [Related]
20. Depression in Parkinson's disease: conceptual issues and clinical challenges. Leentjens AF J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):120-6. PubMed ID: 15312275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]